drugset / Trial / NCT01178138

Monoamine Antagonist Therapies for Methamphetamine Abuse Prazosin

NCT01178138

NaSingle-groupTriple-blindHealth-services research

Summary

This protocol will test the safety, effectiveness and the metabolism and action of prazosin as a potential therapy for methamphetamine abuse. This will be accomplished by performing a series of human laboratory studies. In each of these studies, the safety and effectiveness of the test medication (prazosin) in the treatment of methamphetamine effects will be determined. The study hypothesis is that prazosin will block the methamphetamine receptor function, reducing the reinforcing effects of central nervous system effects in humans.

Timeline

Start
2009-12
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Prazosin Unknown 1 mg Oral
Subject Prazosin Unknown 2 mg Oral

Indications